Pharmaceutical Innovation: Revolutionizing Human Health (The Chemical Heritage Foundation Series in Innovation and Entrepreneurship)

Lardau, Ralph,Achilladelis, Basil,Scriabine, Alexander,Landau, Ralph

ISBN 10: 0941901211 / ISBN 13: 9780941901215

Published by Chemical Heritage Foundation, 1999

About this Item

Connecting readers with great books since 1972! Used books may not include companion materials, and may have some shelf wear or limited writing. We ship orders daily and Customer Service is our top priority!

Seller Inventory # S_477737068

Bibliographic Details

• Title: Pharmaceutical Innovation: Revolutionizing Human Health (The Chemical Heritage Foundation Series in Innovation and Entrepreneurship)
• Publisher: Chemical Heritage Foundation
• Publication Date: 1999
• Language: English
• ISBN 10: 0941901211
• ISBN 13: 9780941901215
• Binding: hardcover
• Condition: Very Good

About this title

Synopsis

A wide-ranging look at an industry that is central to the health and welfare of humanity, this pioneering work documents how science has provided an astonishing array of medicines for coping with human ailments over the last 150 years. Pharmaceutical Innovation covers the history of the pharmaceutical industry and its many contributions to human health. Underpinning the volume is an outline of the five generations of medicine, from the 1820s to present day. The volume also addresses industry leaders, economic influences, and the development of individual products. These factors have particular significance for the pharmaceutical industry today. This book's account of research and development in a key industry makes Pharmaceutical Innovation required reading for policy makers, economists, corporate executives, research managers, and historians of science, technology, and medicine.

About the Author

Ralph Landau is Senior Fellow at Stanford Institute for Economic Policy Research (SIEPR), Consulting Professor of Economics at Stanford University, and Research Fellow at Harvard University's Kennedy School. He was cofounder of the Halcon/Scientific Design Group in 1946 and the Oxirane Company in 1966.

Basil Achilladelis was Senior Administrator of the Environment Directorate for the Organization for Economic Cooperation and Development in Paris. His research focuses on technical innovations in the chemical and pharmaceutical industries.

Alexander Scriabine, M.D., is Editor of Cardiovascular Drug Reviews, Co-editor of CNS Drug Reviews, and a lecturer at Yale University Medical School. He spent thirty-six years in the pharmaceutical industry, at Pfizer, Merck, and Miles Laboratories (now Bayer Corporation).